This document summarizes a health insurance matching company called JibeHealth. It highlights that JibeHealth has a proven profitable business model, having generated $1.5 million in revenue and over $100,000 in profits in 2013, and $2 million in revenue and over $600,000 in profits in 2014. It is seeking $5.7 million in funding to further grow its business and acquire more clients through marketing, expanding its technology platform, and hiring more staff. It projects continued revenue and profit growth through 2019 if successfully funded.
The American Legion - National Emergency Fund Responds to DisastersArthur Godsell
With decades of experience in the construction industry, Arthur Godsell currently leads Godsell Construction Corporation as president of the family-owned business in New York. Arthur Godsell is also dedicated to a variety of philanthropic endeavors, and he supports a host of nonprofit organizations, such as the American Legion.
SnapHealth is raising $1,000,000 of seed funding to revolutionize the individual benefits landscape. Investors will receive Cumulative Preferred Stock with a declared 5% dividend rate. Health Insurance Sucks. Our patent-pending methodologies make it work.
The American Legion - National Emergency Fund Responds to DisastersArthur Godsell
With decades of experience in the construction industry, Arthur Godsell currently leads Godsell Construction Corporation as president of the family-owned business in New York. Arthur Godsell is also dedicated to a variety of philanthropic endeavors, and he supports a host of nonprofit organizations, such as the American Legion.
SnapHealth is raising $1,000,000 of seed funding to revolutionize the individual benefits landscape. Investors will receive Cumulative Preferred Stock with a declared 5% dividend rate. Health Insurance Sucks. Our patent-pending methodologies make it work.
10 Best Healthcare Solution Companies in 2022.pdfinsightscare
Enabling a plethora of such exemplary traits and combining them with innovative solutions, Insights Care features the “10 Best Healthcare Solution Companies in 2022” that are transforming the healthcare niche and reshaping the future of healthcare delivery with a novel approach.
American International Holdings (AMIH) is an investor, developer and asset manager of diversified, synergistic health and wellness businesses. Today, the AMIH portfolio encompasses telemedicine and other virtual health platforms, affordable subscriber-based primary care and concierge medicine plans, preventative care solutions and wellness related assets such as mental & behavioral health services, as well as its own proprietary life coaching platform. AMIH markets its various services through direct-to-consumer and business-to-business distribution channels. AMIH’s focus is on bringing to market technologies and solutions that advance the quality of life for the global community.
When we're sick, we want a person by our bed, not a robot. That's why, by 2030, 100% of healthcare will be in the home, but there is a lot of work yet to be done. The first step, consolidating a fragmented Home Healthcare sector - and that's where we come in.
How SMBs in the UK are embracing social media [2015 Research]LinkedIn Europe
SMBs are driving Europe back to growth, and relying on social media to help them do it. Here’s how to put together a winning social strategy to reach them.
Hiring in a Candidate Driven Marketplace: Attracting & Retaining Superstar Ta...Shelley Reece
Ever wonder how companies differentiate themselves to attract and retain superstar talent?
Join us for a panel event featuring thought leaders from Tolman | Wiker, voted '2017 Best Place To Work' by the Pacific Coast Business Times, as they share insight on the strategies used by top employers to win the war for talent.
Hiring in a Candidate Driven Marketplace: Attracting & Retaining Superstar Ta...Aggregage
Ever wonder how companies differentiate themselves to attract and retain superstar talent?
Join us for a panel event featuring thought leaders from Tolman | Wiker, voted '2017 Best Place To Work' by the Pacific Coast Business Times, as they share insight on the strategies used by top employers to win the war for talent.
Health insurance exchanges critical success factors for payersApoorv S
Health insurance exchanges will significantly impact the healthcare entities and more so the payers. Payers will have to align with the change in focus from B2B model to B2C model and this entails payers to focus on various aspects to succeed. Article outlines key success factors which payers will have to factor in to tide over the changing fundamentals of U.S. healthcare due to the shift towards retail healthcare.
Cover SheetProject Analysis ByMatthew PankeyBBA in Finance2011-20MerrileeDelvalle969
Cover SheetProject Analysis By:Matthew PankeyBBA in Finance2011-2021MGT 4810 W1-W2 Fall 2022
Executive SummaryExecutive Summary Johnson & Johnson is a multinational American company with headquarters in New Bunswick, New Jersey. Medical devices, pharmaceuticals, and consumer health are the three main business sectors of Johnson & Johnson, which was founded in 1886. J&J is a Fortune 500 firm with about 250 subsidiary businesses that operate in more than 60 countries and sell goods in more than 175 nations. To stand out from rivals, Johnson & Johnson relies on its products and innovation. With the help of this company analysis, students can examine every facet of Johnson & Johnson's operations as consultants. This pertinent data may be used to shed light on how J&J might enhance internal and external operations while enhancing its financial performance and stockholder value. The Strategic Management textbook and other trustworthy sources, such as Johnson & Johnson's annual reports, investor website, and news releases, were used to compile all of the information for this research. Through this capstone project, students can examine pertinent corporate finances and gain knowledge about the potential pitfalls of their chosen career pathways.I was able to get substantial Microsoft Excel knowledge with this assignment, which will help me as I begin to improve my career-related skills. Due to the significant study and analysis required to create each tool, I also had to learn good time management techniques. When examining a company's financials and annual reports to estimate its value, I also feel as though I learned knowledge.
Table of ContentsTable of ContentsTool 1:Historical AnalysisPage 4Tool 2:Mission Statement AnalysisPage 5Tool 3:Remote Environment AnalysisPage 7Tool 4:Competitive Profile MatrixPage 12Tool 5:Internal Factor EvaluationPage 14Tool 6:CohesionPage 17Tool 7:Generic StrategyPage 20Tool 8:Perceptual MappingPage 22Tool 9:GlobalizationPage 23Tool 10:Financial Ratios and BenchmarkingPage 25Tool 11:SWOTPage 30Tool 12:Financing Recommendations for SWOTPage 35
Tool 1Historical AnalysisPurpose: Identify which strategies have historically been successful and how they have affected revenue by relating recent strategic events inside the company to consumer health, medicines, medical devices, and overall revenues. Findings from this research will be used in a SWOT analysis to identify strengths and weaknesses. Data was taken from yearly reports by Johnson & Johnson.YearsGross RevenueConsumer HealthPharmaceuticalMedical Devices2011$82,584$14,053$45,572$22,9592012$82,059$13,898$42,198$25,9632013$81,581$13,853$40,734$26,9942014$76,450$13,602$36,256$26,5922015$71,890$13,307$33,464$25,1192016$70,074$13,507$31,430$25,1372017$74,331$14,496$32,313$27,5222018$71,312$14,697$28,125$28,4902019$67,224$14,447$25,351$27,4262020$65,030$14,883$24,368$25,7792021$93,775$14,635$52,080$27,060Recent Strategic Events2, 3March 2011: Acquires Crucell, a biopharmac ...
This document brings together a set
of latest data points and publicly
available information relevant for
Healthcare Industry. We are very
excited to share this content and
believe that readers will benefit from this periodic publication immensely.
This is our Parkway Healthcare Ventures Overview. We are answering the cry for healthcare in rural America. In the process, we have also developed a demonstratively different investment opportunity. Everyone wins with our solution; the physicians looking to sell their practices in rural America, the patients that live in rural America that are lacking enhanced medical care with a variety of modalities and our investors. We offer an investment opportunity in healthcare using an interest bearing convertible note.
Please contact me for more details.
David Federico
david@parkwayhealthcareventures.com
770 713.1243
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Crowdfunding Slide Deck
1. Proven Machine | Battle Tested Team | Profitable Traction
Get Matched
with the right health plan
1
2. Consumers choose the wrong Health
Plan up to 88% of the time.
Consumers choose the
wrong Health Plan up to
88% of the time.
Problem
2
3. Consumers choose the wrong Health
Plan up to 88% of the time.
1. Consumers unable to make clear decision based on
their needs.
2. The Average Consumer stands to loose up to half a
year salary for a family of four
3. Costing Tax Payers $9 Billion a Year for consumer
errors
4. Lower Member Retention
Pain
3
4. Tax Penalties
• The Tax penalties for
individuals without
health coverage
increases substantially
in 2014 and rises again
in 2015.
50 Million
Uninsured
• As a result we expect
that a large number of
the current uninsured
population of 50 million
will enter the individual
health insurance
market. Accordingly,
after 2014,
Small Business
• Department of labor
statistic identify that
90% of American small
business have less than
50 employees
Employers Dropping
Coverage
• The McKinsey survey
estimates that
approximately 30% of
employers would
“definitely” or
“probably” drop
employer-sponsored
insurance starting in
2014.
• Employers dropping
group coverage and an
additional 45 million
uninsured Americans
entering the individual
insurance market
Up to 80% of
consumers pick
wrong plan
• Consumers have a lower
quality of care
• Pay more out of pocket
• Lower persistency of
enforce policies
Continued Pain
4
5. 2M in
Revenue
in 2014
600k+ in
Net
Income
2014
100,000
Customers
Assisted
Proven
Marketing
Campaigns
Licensed
in 24
States
Client
Retention
and
Customer
Service
Upsell
and
Parallel
Product
Offerings
Product
Offering
(Health,
Life,
Dental,
Critical,
Accident)
February 2013
•Bootstrapped with 300K by
Founders
•Delivered 14,000 policies
September 2013
•100% Internal Client
Acquisition from in house
marketing campaigns
September 2014
•Awarded CMS HHS contract
to offer “Obamacare” plans
in all states
December 2014
•Integrated Web Broker
Entity and Qualified Health
Plan and Real Time Federal
Facilitated Marketplace
data directly into
JibeHealh.com
May 2015
•Completed CMS/HHS data
hub integration and in beta.
Traction
5
6. We use advanced analytics to match
you with a Health Plan based on your
individual needs and help you get
the money to pay for it!
Solution
6
8. Client Acquisition occurs from the Web
through our JibeHealth.com platform or
over the phone via a licensed Agent.
Our platform matches the right Health and
Medical Insurance products based on loves
and needs of consumers.
Backend Client Retention and Customer
care follows life cycle of customer and
policy to maximize retention of members.
Marketing of new product offerings and
ancillary products to existing members.
Click or Call
Match the
Right Product
Client
Retention and
Customer Care
New Product
Offerings
Client Gestation
8
9. 37 Million 15 Million
53M
JibeHealth
Playground
37M without Health Insurance and a addition 15.7M
currently in the Health Exchange Market Place
Market Overview
9
14. 0.00%
2.00%
4.00%
6.00%
8.00%
10.00%
12.00%
14.00%
16.00%
18.00%
20.00%
FL TX GA IL CA PA VA NC OH MD TN LA AL MO NY AZ IN MS WA KY SC CO
AxisTitle
JibeHealth Generated Calls Compared to CMS Generated Calls by State
Comparison of Healthcare.gov Enrollment to Calls Generated in our Target Markets
2013-2014
Percentage of Calls by State: JibeHealth Percentage of Enrolled by HHS/Healthcare.gov by State 14
16. We a have a proven profitable model and battle tested team
We generated revenues 1.5 M with net profits in excess of $100K for fiscal 2013.
We generated revenues of 2 million with net profits in excess of $600K for fiscal 2014
100% boot-strapped by founders
Seeking: Funding / Series A - 5.7 Million in Equity /Convertible Debenture
Funding timeline 90 days
Use of Proceeds: Client Acquisition 60%
Technology Platform complete build 20%
New Hires / Staffing 20%
Return on Investment 12 Month Return of Capital Invested
18 Months 24M in Revenue / 8M Net Income
24 Months 60M in Revenue / 37M Net Income
36 Months 104M in Revenue / 59M Net Income
16
Capital Requirement
17. Peter Colon – Co Founder
Chief Executive Officer
Peter leads the entire organization bringing with him a strong skill set of leadership acquired early on in the United States Navy & Marine Corp acquiring the
Achievement Medal and Battle Efficiency Medals. Peter took his leadership abilities an applied them to the world of Finance and Insurance with tenures at
AXA equitable, Mass mutual and BeamaLife. Peter’s insider’s knowledge of the insurance world combined with his vision of impactful technological
applications within these old school markets makes for execution that packs a punch. Peter has received inspiration and personal mentorship from some of
Americas most talented CEO’s including George Feldenkrais – Perry Ellis CEO, Manny Medina – Terremark Corporation. Peter holds licenses in 45 States and is
CMS/HHS Certified. Peter is often called as a key note speaker for the various charities he is involved in “We Do Art” Miami based nonprofit “Food for Life
Network” Miami Based food bank for families with HIV. Peter is Married with three children and lives in Miami Florida
George Theodore – Co Founder
Chief Operating Officer
George Theodore is a seasoned serial entrepreneur with well over twenty years’ experience in capital markets, sales, marketing and public relations. Mr.
Theodore is a gifted communicator well skilled in identifying emerging market trends and understanding the multiplicity of consumer phycology. Georges
experience has empowered him with a diverse breadth of knowledge and success across multiple industries and markets. Mr. Theodore is responsible for the
company’s go to market strategy and leads in the development and execution of the company’s global vision. George was born with terminal optimism and
suffers from a severe positive mental attitude. Mr. Theodore has been published and featured in several media publications including, Marketing Magazine,
Ad Age, The Wall Street Reporter.com, Report on Business. George is an avid collector of vintage mobile devices, Mr. Theodore has a daughter and resides in
Palm Beach Florida.
Shane McIntyre – Co Founder
Chief Technology Officer
Shane is a native Floridian who earned his Bachelor’s Degree in Computer Science at Florida Atlantic University. Certified in Microsoft , ITIL, PMI Shane comes
packing with over 20 Years of experience leading Information technology across a variety of verticals Shane has managed large enterprise companies and
technology startups. Shane started his career out at PBS&J now Akins Engineering. Having lead successful technology startups Shane understands the
intimate relationship between technology and marketing. Shane has the unique ability to align technology around the strategic goals and vision of the
company while executing with precision. Shane’s core belief is that technology must provide value both in generating revenue and provide efficiency across all
channels and service lines. Shane makes an exceptional Tech- Hoagie wrapping good processes, with great people and superb products to deliver exceptional
value and leadership for the firm, stakeholders, and investors
17
TeamJibe